StonvexLoading…
StonvexStonvexStonvexCore line items from PED's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $45.75M | $39.55M | $30.78M | $30.78M |
Operating Income | $-7.86M | $4.72M | $1.24M | $2.63M |
Net Income | $-10.36M | $12.29M | $1.70M | $2.84M |
EPS (Diluted) | $-2.25 | $2.76 | $0.02 | $0.03 |
Total Assets | $375.87M | $128.35M | $122.74M | $116.11M |
Total Liabilities | $168.50M | $12.74M | $21.29M | $19.65M |
Cash & Equivalents | $3.22M | $4.01M | $18.52M | $29.43M |
Free Cash Flow OCF − CapEx | Not available | Not available | $23.44M | $15.98M |
Shares Outstanding | 4.80M | 4.47M | 87.25M | 85.79M |